1. Home
  2. KRNT vs LQDA Comparison

KRNT vs LQDA Comparison

Compare KRNT & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRNT
  • LQDA
  • Stock Information
  • Founded
  • KRNT 2002
  • LQDA 2004
  • Country
  • KRNT Israel
  • LQDA United States
  • Employees
  • KRNT N/A
  • LQDA N/A
  • Industry
  • KRNT Industrial Machinery/Components
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • KRNT Industrials
  • LQDA Health Care
  • Exchange
  • KRNT Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • KRNT 1.4B
  • LQDA 1.3B
  • IPO Year
  • KRNT 2015
  • LQDA 2018
  • Fundamental
  • Price
  • KRNT $19.59
  • LQDA $14.52
  • Analyst Decision
  • KRNT Strong Buy
  • LQDA Strong Buy
  • Analyst Count
  • KRNT 5
  • LQDA 7
  • Target Price
  • KRNT $34.00
  • LQDA $28.33
  • AVG Volume (30 Days)
  • KRNT 293.1K
  • LQDA 887.5K
  • Earning Date
  • KRNT 05-07-2025
  • LQDA 03-19-2025
  • Dividend Yield
  • KRNT N/A
  • LQDA N/A
  • EPS Growth
  • KRNT N/A
  • LQDA N/A
  • EPS
  • KRNT N/A
  • LQDA N/A
  • Revenue
  • KRNT $203,825,000.00
  • LQDA $13,996,000.00
  • Revenue This Year
  • KRNT $11.22
  • LQDA $256.78
  • Revenue Next Year
  • KRNT $12.76
  • LQDA $222.00
  • P/E Ratio
  • KRNT N/A
  • LQDA N/A
  • Revenue Growth
  • KRNT N/A
  • LQDA N/A
  • 52 Week Low
  • KRNT $13.59
  • LQDA $8.26
  • 52 Week High
  • KRNT $34.29
  • LQDA $16.81
  • Technical
  • Relative Strength Index (RSI)
  • KRNT 33.35
  • LQDA 45.00
  • Support Level
  • KRNT $18.70
  • LQDA $14.41
  • Resistance Level
  • KRNT $22.30
  • LQDA $15.09
  • Average True Range (ATR)
  • KRNT 0.93
  • LQDA 0.65
  • MACD
  • KRNT -0.01
  • LQDA -0.06
  • Stochastic Oscillator
  • KRNT 20.46
  • LQDA 26.37

About KRNT Kornit Digital Ltd.

Kornit Digital Ltd develops, designs and markets digital printing solutions for the world-wide printed textile industry. The company focuses on its DTG and DTF segments of the printed textile industry. Its solutions include digital printing systems, ink and other consumables, associated software and value-added services that allow for large-scale printing of short runs of complex images and designs directly on finished garments and fabrics. It generates revenue from sales of systems, ink and other consumables and service including software subscriptions The company geographically operates in U.S., EMEA, Asia Pacific and other countries. It derives maximum revenue from U.S.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: